STAAR Surgical Company (STAA) — Stock Score Summary

STAAR Surgical Company (STAA) has a MoatMap StockRank of 64/100 based on Quality (53/100), Value (23/100), and Momentum (72/100) factor scores. The current signal is HOLD. STAAR Surgical has a strong product in implantable Collamer lenses, but it lacks direct alignment with our 18-month macro themes and is currently facing growth normalization in key markets like China.

STAAR Surgical Company designs, develops, manufactures, and markets implantable lenses for the eye, primarily its proprietary EVO Visian Implantable Collamer Lens (ICL) for vision correction. The company holds a leadership position in the premium refractive vision correction market due to its unique, patented ICL technology offering superior visual outcomes for suitable patients. It benefits from high barriers to entry in ophthalmology and growing market acceptance of its advanced lens solutions.

Key Financial Metrics

Price$29.87
Market Cap$1.4B
P/E (Forward)30.24
Price/Book4.29
Return on Equity-6.0%
Return on Invested Capital-12.0%
Debt/Equity10.58
Gross Margin76.9%
Operating Margin18.7%
Revenue Growth119.6%
Free Cash Flow$-18M

STAAR Surgical Company operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is STAAR Surgical Company’s (STAA) StockRank?
MoatMap’s StockRank for STAAR Surgical Company (STAA) is 64/100, with a Hold signal. It is a composite of Quality (53), Value (23), and Momentum (72) factor ranks across MoatMap’s 19,000+ stock universe.
Does STAAR Surgical Company have an economic moat?
STAAR Surgical Company (STAA) has a Quality factor score of 53/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is STAAR Surgical Company a buy, hold, or sell?
MoatMap’s current signal for STAAR Surgical Company (STAA) is Hold, based on a StockRank of 64/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is STAAR Surgical Company in?
STAAR Surgical Company (STAA) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (United States).